Dr. Mirsaeidi graduated with high honors and distinction from his medical school in Iran and completed a Master of Public Health, residency and fellowship in Infectious Diseases there. He was a Chief Resident and won several honors nationally and internationally. During this residency and fellowship, he distinguished himself by completing several large clinical research projects. He had a leading role in the first clinical trial for multidrug resistant tuberculosis treatment in Iran. He continued these activities when he came to the United States in 2006. He joined the group of Dr. Julio Ramirez in Division of Infectious Diseases at the University of Louisville. He was acknowledged for his contributions in clinical research in pulmonary infection in 2007 and 2008. He published several articles with significant impact in pneumonia including introducing thrombocytosis as a marker for poor outcome in patients with community-acquired pneumonia and IBMP-10 as a prognostic tool for patients with ventilator-associated pneumonia.
After completing an Internal Medicine residency, he joined the University of Illinois at Chicago (UIC) as a pulmonary and critical care fellow in July 2011. He immediately began two clinical research projects on nontuberculous mycobacterial infection, including one on bronchiectasis and sarcoidosis. He also continued his research in tuberculosis. He developed first sarcoidosis clinical dataset in UIC and performed several translational projects on fibrosing pulmonary sarcoidosis. He is also concerned about health disparities and climate change. He recently joined the University of Miami and has been developing the UM sarcoidosis program.
Sarcoidosis; Tuberculosis; Nontuberculous mycobacteria; Bronchiectasis.